Detalhe da pesquisa
1.
Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II study.
J Infect Dis
; 209(4): 542-50, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23983212
2.
ARIES 144 week results: durable virologic suppression in HIV-infected patients simplified to unboosted atazanavir/abacavir/lamivudine.
HIV Clin Trials
; 13(5): 233-44, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23134624
3.
Safety and efficacy of a 36-week induction regimen of abacavir/lamivudine and ritonavir-boosted atazanavir in HIV-infected patients.
HIV Clin Trials
; 11(2): 69-79, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20542844
4.
Estimated glomerular filtration rates through 144âweeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine.
HIV Clin Trials
; 16(4): 125-9, 2015 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26133089
5.
Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks.
HIV AIDS (Auckl)
; 9: 51-61, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28424561
6.
Phenotypic and genotypic analysis of influenza viruses isolated from adult subjects during a phase II study of intravenous zanamivir in hospitalised subjects.
Antiviral Res
; 134: 144-152, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27568923
7.
Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial.
PLoS One
; 9(5): e96187, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24825167
8.
Inflammatory biomarker changes and their correlation with Framingham cardiovascular risk and lipid changes in antiretroviral-naive HIV-infected patients treated for 144 weeks with abacavir/lamivudine/atazanavir with or without ritonavir in ARIES.
AIDS Res Hum Retroviruses
; 29(2): 350-8, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23039030
9.
Similar efficacy and tolerability of atazanavir compared with atazanavir/ritonavir, each with abacavir/lamivudine after initial suppression with abacavir/lamivudine plus ritonavir-boosted atazanavir in HIV-infected patients.
AIDS
; 24(13): 2019-27, 2010 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-20613461